Evidence map›Paper›PMID 36191597›Full record

Trial reportFacial plastic surgery : FPS2023

Efficacy and Safety of Polycaprolactone in Treating Nasolabial Folds: A Prospective, Multicenter, and Randomized Controlled Trial.

Hongyi Zhao, Rongxin Ren, Shiwei Bao, Wenjiang Qian, Xiaobing Ma, Ruiyan Wang, Xiaoxin Li, Rouyu Fang, Qiuning Sun, Yan Tian and 2 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Facial plastic surgery : FPS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hongyi ZhaoDepartment of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Rongxin RenDepartment of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Shiwei BaoDepartment of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Wenjiang QianDepartment of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Xiaobing MaDepartment of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Ruiyan WangDepartment of Dermatology, Air Force Characteristic Medical Center, Beijing, People's Republic of China.
Xiaoxin LiDepartment of Dermatology, Air Force Characteristic Medical Center, Beijing, People's Republic of China.
Rouyu FangDepartment of Dermatology, Peking Union Medical College Hospital, Beijing, People's Republic of China.
Qiuning SunDepartment of Dermatology, Peking Union Medical College Hospital, Beijing, People's Republic of China.
Yan TianDepartment of Dermatology, Air Force Characteristic Medical Center, Beijing, People's Republic of China.
Chaonan ZhuHuadong Medical Co. Ltd, Hangzhou, People's Republic of China.
Jianling ShiHuadong Medical Co. Ltd, Hangzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasolabial folds (NLFs) are the most pronounced sign of facial aging. This study explored the efficacy and safety of polycaprolactone gel in treating Chinese patients with moderate-to-severe NLFs. Patients with moderate-to-severe NLF who wished to be treated by dermal fillers were recruited from three centers between July 2017 and September 2019. The randomizing ratio was 1:1 in the polycaprolactone group (polycaprolactone injection) or control group (sodium hyaluronate gel injection). The primary endpoint was the effectiveness rate of Wrinkle Severity Rating Score (WSRS) scores at 12 months after injection. The full-analysis set (FAS) and safety sets had 80 patients in the polycaprolactone group and control group, respectively. In the FAS, the effectiveness rate at 12 months in the polycaprolactone group was 88.8% compared with 23.8% in controls (

Indexed as

Cosmetic TechniquesDermal FillersSkin AgingEsthetics, DentalHumansHyaluronic AcidNasolabial FoldPolyestersProspective StudiesTreatment OutcomeDermal FillersHyaluronic AcidpolycaprolactonePolyesters

Identifiers

PMID36191597
PMCPMC10171959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.